通过分心器的重复来减少萨卡迪克抑制
Yijing Shan1, Jay A Edelman2,3
1Doctoral Program in Biology, The Graduate Center of The City University of New York, New York, New York, United States.
Journal of neurophysiology
|July 19, 2023
概括
由于视觉分心因素导致的眼睛运动减少,被重复的分心刺激显著减少. 这表明一种机制可以抑制经常出现的视觉刺激.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 视觉科学 视觉科学 视觉科学
背景情况:
- 斜视抑制是一种现象,在这种现象中,斜视眼动被视觉分心器抑制.
- 视觉适应,即对重复刺激的神经反应的减少,发生在像上结膜 (SC) 这样的大脑区域.
- 该SC在萨卡迪眼动生成中发挥着至关重要的作用.
研究的目的:
- 调查重复的视觉分心剂是否会降低人类的萨卡迪克抑制.
- 探索刺激重复和空间概括对萨卡迪克抑制的影响.
主要方法:
- 在人类参与者身上,采用了记忆引导的动任务.
- 呈现了视觉分心因素,其重复和空间位置的变化.
- 测量了对分心刺激的响应时的萨卡德执行频率.
主要成果:
- 干扰器的重复显著降低了当干扰器出现在相反的萨卡德目标时的萨卡德抑制.
- 空间分布的干扰器重复也导致了中介性抑制的减少,表明了泛化.
- 刺激重复对萨卡迪克抑制的影响很大,在很大程度上消除了抑制.
结论:
- 通过适应机制,重复的视觉刺激可以显著减少节抑制.
- 一个干扰抑制机制可能存在,以减轻频繁的视觉刺激对目标定向眼球运动的影响.
- 这一发现突显了视觉刺激背景对动态环境中的顺序控制的影响.
更多相关视频
10:38A Cognitive Paradigm to Investigate Interference in Working Memory by Distractions and Interruptions
Published on: July 16, 2015
13.7K
06:46Investigating the Deployment of Visual Attention Before Accurate and Averaging Saccades via Eye Tracking and Assessment of Visual Sensitivity
Published on: March 18, 2019
7.1K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...